• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders

AI Agent for Financial Markets across Forex, Commodities, Options, Stocks, and Crypto.

© Copyright 2026 Diplyzer, All Rights Reserved.

About
  • Blog
  • Contact
Product
  • Documentation
Legal
  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Refund Policy
  • Disclaimer
AMGN

AMGN

Amgen Inc.

NASDAQHealthcareDrug Manufacturers - GeneralUS

USD331.57

+0.82 (+0.25%)

Rating:B+

Open

330.75

Prev. Close

330.75

Day Low

326.80

Day High

333.53

52W Low

267.83

52W High

391.29

Market Cap

$178.95B

Volume

3.92M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

57.7%

Avg Negative

10.3%

Avg Neutral

32.0%

News Feed

Guggenheim Trims Amgen Price Target to $340: Is the Biotech Giant Losing Its Edge?

247wallst.com·5/4/2026·↓ negative

Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know

zacks.com·5/4/2026·↑ positive

Amgen to invest additional $300 million to boost US manufacturing footprint

reuters.com·5/4/2026
·↑ positive

AMGEN ANNOUNCES ADDITIONAL $300 MILLION U.S. MANUFACTURING INVESTMENT, TOTALING NEARLY $2 BILLION OVER THE LAST YEAR

prnewswire.com·5/4/2026·↑ positive

AMGN DCF Analysis: Intrinsic Value $268 vs Price $330

gurufocus.com·5/4/2026·↑ positive

Amgen's Q1 Earnings Top Estimates, 16 Drugs Deliver Double-Digit Gains

zacks.com·5/1/2026·↑ positive

Amgen Inc. (AMGN) Q1 2026 Earnings Call Transcript

seekingalpha.com·5/1/2026·↓ negative

Amgen Inc (AMGN) Q1 2026 Earnings Call Highlights: Strong Product Sales Growth Amidst Competitive Challenges

gurufocus.com·5/1/2026·↑ positive

Amgen (AMGN) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

zacks.com·4/30/2026·↑ positive

Amgen (AMGN) Q1 Earnings and Revenues Beat Estimates

zacks.com·4/30/2026·↑ positive